Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat, Youssef M.K. Farag, Robert D. Toto, Sanjay Kaul, Robert Lawatscheck, Katja Rohwedder, Luís M. Ruilope, Peter Rossing, Bertram Pitt, Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Augusto Vallejos, Richard J. MacIsaac, Guntram Schernthaner, Pieter Gillard, Maria Eugênia Fernandes Canziani, Theodora Temelkova‐Kurktschiev, Ellen Burgess, Sheldon W. Tobe, Zhihong Liu, Andrés Ángelo Cadena Bonfanti, Carlos Jaramillo, Martin Prázný, Jorma Strand, Roland E. Schmieder, Christoph Wanner, Pantelis Sarafidis, Juliana C.N. Chan, László Rosivall, Joseph A. Eustace, Giuseppe Remuzzi, Daisuke Koya, Takashi Wada, Magdalena Madero Rovalo, Ron T. Gansevoort, Adriaan Kooy, Trine Finnes, Froilan DeLeon, Janusz Gumprecht, Fernando Teixeira e Costa, Anantharaman Vathsala, Aslam Amod, Sin Gon Kim, Byung‐Wan Lee, Julio Pascual Santos, Bengt-Olov Tengmark, Michel Burnier, Chien‐Te Lee, Sukit Yamwong, Ramazan Sarı, Kieran McCafferty, Borys Mankovsky, Sharon G. Adler, Linda F. Fried, Mark V. Williams, Tran Quang Khanh, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Peak Mann Mah, Craig Nelson, Alexia Pape, Hugo Stephenson, Michael Suranyi, Elizabeth Vale, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer (2023). Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes. , 176(12), DOI: https://doi.org/10.7326/m23-1023.
Article49 days agoSupplementary Material for: The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics
Wong M.G., Jun Lv, Hladunewich M.A., Jha V., Hooi L.S., Helen Monaghan, Mingfang Zhao, Sean Barbour, R. N., Daniel Cattran, Richard J. Glassock, Anna Levin, Jardine M.J., Wheeler D.C., Mark Woodward, Laurent Billot, Chan T.M., Hongbo Liu, Johnson D.W., Alan Cass, J. Feehally, Jürgen Floege, Giuseppe Remuzzi, Yi‐Long Wu, Rajiv Agarwal, Hengguo Zhang, Vlado Perkovic, for the TESTING Study GroupSupplementary Material for: The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics. , DOI: https://doi.org/10.6084/m9.figshare.16922857.
Dataset49 days agoSupplementary Material for: Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy
Luís M. Ruilope, Rajiv Agarwal, Juliana C.N. Chan, Mark E. Cooper, Ron T. Gansevoort, Harold S. Haller, Giuseppe Remuzzi, Peter Rossing, R. E. Schmieder, Christina NowackSupplementary Material for: Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy. , DOI: https://doi.org/10.6084/m9.figshare.5127541.
Dataset49 days agoPosition Statement from ADA/AACE/EASD/TES in Response to a Recently Published Letter to the Editor in <b><i>The Lancet </i></b>and an Editorial Addressing the Israeli-Palestinian Fighting in Gaza
Wei Deng, Yile Ren, Xuebing Feng, Genhong Yao, Weiwei Chen, Yue Sun, Hengjin Wang, Xiang Gao, Lingyun Sun, Luís M. Ruilope, Peter Rossing, Rajiv Agarwal, Juliana C.N. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Roland E. Schmieder, Christina Nowack, Anna Carolina Galvão Ferreira, Alexander Pieper, Nina Kimmeskamp‐Kirschbaum, George L. Bakris, Sharon M. Moe, Ranjani N. Moorthi, Cheryl Armstrong, Kevin Janda, Kristen Ponsler-Sipes, John R. Asplin, Kyoko Satō, Tomoshige Hayashi, Shinichiro Uehara, Shigeki Kinuhata, Keiko Oue, Ginji Endo, Hiroshi Kambe, Kanji Fukuda, Tomoyuki Kawada, Mae Thamer, Yi Zhang, James S. Kaufman, Onkar Kshirsagar, Dennis J. Cotter, Miguel A. Hernán, Chie Ogawa, Ken Tsuchiya, Fumiyoshi Kanda, Teiryo Maeda, Jay A. White, Joel Z. Melnick, Charles W. Bishop, Xiao‐Yan Bai, Jian Geng, Li Xiao, Fang Yang, Jianwei Tian, Teresa Arcidiacono, Alessandra Mingione, Lorenza Macrina, Francesca Pivari, Laura Soldati, Giuseppe Vezzoli, Jenise Stephen, Teresa L. Anderson-Haag, S.K. Gustafson, Jon J. Snyder, Bertram L. Kasiske, Ajay K. Israni, Stuart M. Sprague, Arnold L. Silva, Fahd Al-Saghir, Radhika Damle, Samir Tabash, Martin Petkovich, Eric J. Messner, Satz Mengensatzproduktion, Druckerei Stückle, Druckerei Stückle (2014). Position Statement from ADA/AACE/EASD/TES in Response to a Recently Published Letter to the Editor in <b><i>The Lancet </i></b>and an Editorial Addressing the Israeli-Palestinian Fighting in Gaza. , 40(6), DOI: https://doi.org/10.1159/000369841.
Article49 days agoSelective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Dick de Zeeuw, Rajiv Agarwal, Michael Amdahl, Paul Audhya, Daniel W. Coyne, Τushar Garimella, Hans‐Henrik Parving, Yili Pritchett, Giuseppe Remuzzi, Eberhard Ritz, Dennis L. Andress (2010). Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. , 376(9752), DOI: https://doi.org/10.1016/s0140-6736(10)61032-x.
Article49 days ago